TTY Biopharm Co Ltd Total Liabilities

Latest as of March 2026: NT$4.28 Billion TWD ≈ $134.75 Million USD

TTY Biopharm Co Ltd total liabilities. Based on the latest financial reports, TTY Biopharm Co Ltd (4105) has total liabilities worth NT$4.28 Billion TWD (≈ $134.75 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 4105 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of TTY Biopharm Co Ltd (2017–2025)

Total liabilities of TTY Biopharm Co Ltd from 2017 to 2025. This chart illustrates how TTY Biopharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data.

TTY Biopharm Co Ltd Competitors by Total Liabilities

The table below lists competitors of TTY Biopharm Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Qingdao Citymedia Co Ltd SHG:600229	China	CN¥1.04 Billion
Shanghai Sanyou Medical Co Ltd SHG:688085	China	CN¥247.79 Million
Shenzhen Centralcon Investment Holding Co Ltd SHE:000042	China	CN¥30.05 Billion
Mensch und Maschine Software SE F:MUM	Germany	€116.41 Million
Yunnan Coal & Energy Co Ltd SHG:600792	China	CN¥5.91 Billion
Alligo AB Series B ST:ALLIGO-B	Sweden	Skr5.91 Billion
Ponsse Oyj 1 HE:PON1V	Finland	€218.38 Million
Zhejiang Unifull Industrial Fibre Co Ltd SHE:002427	China	CN¥1.42 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down TTY Biopharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 4105 total asset value.

Liquidity & Leverage Metrics

TTY Biopharm Co Ltd Total Liabilities Ratios Explained

TTY Biopharm Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.71	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.65	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.37	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how TTY Biopharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for TTY Biopharm Co Ltd (2017–2025)

The table below shows the annual total liabilities of TTY Biopharm Co Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	NT$3.30 Billion ≈ $103.86 Million	-1.64%
2024-12-31	NT$3.35 Billion ≈ $105.60 Million	-0.50%
2023-12-31	NT$3.37 Billion ≈ $106.13 Million	+0.04%
2022-12-31	NT$3.37 Billion ≈ $106.09 Million	-4.59%
2021-12-31	NT$3.53 Billion ≈ $111.19 Million	+7.51%
2020-12-31	NT$3.28 Billion ≈ $103.42 Million	-2.98%
2019-12-31	NT$3.38 Billion ≈ $106.60 Million	+27.13%
2018-12-31	NT$2.66 Billion ≈ $83.85 Million	-21.61%
2017-12-31	NT$3.40 Billion ≈ $106.97 Million	--

About TTY Biopharm Co Ltd

TWO:4105 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$620.44 Million

NT$19.69 Billion TWD

Market Cap Rank

#10819 Global

#365 in Taiwan

Share Price

NT$79.20

Change (1 day)

-1.25%

52-Week Range

NT$72.10 - NT$86.30

All Time High

NT$97.91